The Centers for Disease Control and Prevention (CDC) has confirmed 3,887 measles cases in the United States as of October 1, ...

The VAX-31 pneumococcal conjugate vaccine (PCV) candidate met all prespecified primary endpoints in OPUS-1, the pivotal adult phase 3 trial, according to the vaccine’s manufactu ...

FDA-cleared single-step immunoblot tests built on recombinant antigens from multiple Borrelia species detected nearly twice ...

A 28-year-old laboratory technician at the Irkutsk Research Anti-Plague Institute of Siberia, in Shelekhov, Russia, has died ...

A 28-year-old laboratory technician at the Irkutsk Research Anti-Plague Institute in Shelekhov, Siberia, has died after developing severe pneumonia, with Russian media and regional officials pointing ...

Today, the Centers for Disease Control and Prevention (CDC) reported there were 3887* cases of measles in the US as of October 1, 2026. Week-over-week, this is an additional 228 c ...

New data from PETERPEN suggest that piperacillin-tazobactam may be noninferior to meropenem for early clinical outcomes in ...

Recent urinary tract infection guideline updates from multiple international medical societies highlight evolving recommendations, including a major shift in classification, moving from anatomy- and ...

With a significant increase in rabies exposures this year, Rodney Rohde, PhD, talks about seeking medical attention after ...

The investigational monoclonal antibody, VYD2311, (Invivyd) met all primary and key secondary endpoints in the phase 3 LIBERTY study. It showed safety and tolerability superior to an mRNA-based ...

With the potential need to understand further what presentation and treatment, look like, Lori Handy, MD, MSCE, associate director of the Vaccine Education Center and an attending physician in the ...

Lori Handy, MD, provides guidance in these areas including presentation before rash onset, when patients should be considered for the inpatient setting, and what treatment looks like.